Insider Selling: Stryker (NYSE:SYK) Insider Sells $144,917.01 in Stock

Stryker Corporation (NYSE:SYK) insider Dylan Bram Crotty sold 441 shares of the firm’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the transaction, the insider directly owned 6,102 shares of the company’s stock, valued at $2,005,178.22. The trade was a 6.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Stryker Stock Up 2.9%

SYK opened at $331.32 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86. The firm has a market capitalization of $127.08 billion, a P/E ratio of 34.33, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76. The company has a fifty day moving average price of $329.10 and a 200-day moving average price of $331.47.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating analysts’ consensus estimates of $3.49 by $0.20. The business had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker’s quarterly revenue was up 9.4% on a year-over-year basis. During the same period last year, the firm posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities research analysts expect that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio is presently 36.48%.

Wall Street Analyst Weigh In

SYK has been the subject of a number of recent research reports. Argus set a $370.00 target price on Stryker in a research report on Thursday, July 9th. Wolfe Research cut shares of Stryker from an “outperform” rating to a “peer perform” rating in a research report on Thursday, August 13th. Royal Bank Of Canada lowered their price objective on shares of Stryker from $435.00 to $420.00 and set an “outperform” rating for the company in a report on Friday, July 31st. Sanford C. Bernstein set a $410.00 price objective on shares of Stryker in a research note on Friday, May 1st. Finally, BMO Capital Markets assumed coverage on shares of Stryker in a report on Wednesday, July 8th. They set an “outperform” rating and a $369.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and an average target price of $386.28.

Hedge Funds Weigh In On Stryker

A number of large investors have recently bought and sold shares of SYK. California State Teachers Retirement System boosted its stake in shares of Stryker by 30,523.4% during the second quarter. California State Teachers Retirement System now owns 163,395,348 shares of the medical technology company’s stock valued at $51,443,391,000 after purchasing an additional 162,861,784 shares during the period. State Street Corp increased its stake in shares of Stryker by 2.1% in the fourth quarter. State Street Corp now owns 15,254,407 shares of the medical technology company’s stock worth $5,374,731,000 after buying an additional 311,507 shares during the period. Wellington Management Group LLP raised its holdings in Stryker by 0.6% during the 2nd quarter. Wellington Management Group LLP now owns 8,167,185 shares of the medical technology company’s stock valued at $2,571,357,000 after buying an additional 45,478 shares during the last quarter. Geode Capital Management LLC raised its holdings in Stryker by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company’s stock valued at $2,636,238,000 after buying an additional 69,851 shares during the last quarter. Finally, Norges Bank purchased a new stake in Stryker during the 4th quarter valued at $1,822,272,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.